Two out of three people in the US suffer from hypertension or pre-hypertension. Of those taking anti-hypertensive medication, only about 50% have their blood pressure properly managed. High blood pressure is the primary risk factor for onset and progression of cardiovascular disease.

Our patented NO technology normalizes blood pressure safely and effectively; these claims are supported by several published studies in which AusTech technology was utilized as a therapeutic for hypertension. Outcomes are detailed below:

Effects of an Oral Nitric Oxide Supplement on Functional Capacity and Blood Pressure in Adults With Prehypertension

  • Conducted at Cedars Sinai┬áMedical Center in Los Angeles, CA by Ernst Schwarz, MD, PhD
  • Published in the Journal of Cardiovascular Pharmacology and Therapeutics
  • Group receiving Nitric Oxide supplementation exhibited 12 mm Hg reduction in systolic and 6 mm Hg reduction in diastolic blood pressures


Acute Effects of an Oral Nitric Oxide Supplement on Blood Pressure, Endothelial Function, and Vascular Compliance in Hypertensive Patients

  • Conducted at the Hypertension Institute in Nashville, TN by Mark Houston, MD, MS, MSc
  • Published in The Journal of Clinical Hypertension
  • Nitric Oxide supplementation resulted in statistically significant reduction of systolic and diastolic blood pressure, improvement in vascular compliance, and improvement in endothelial function as measured by EndoPAT